Clinical trial
Post-Market Clinical Follow-up Study of Edwards Lifesciences MITRIS RESILIA Mitral Valve in Chinese Population
NCT07059793 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Market Clinical Follow-up Study of Edwards Lifesciences MITRIS RESILIA Mitral Valve in Chinese Population
- Lead sponsor
- Edwards Lifesciences
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 8, 2025
- Completion date
- December 31, 2038
- Enrollment
- 250 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
mitral valve replacement